Tupper Colleen 4
4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Feb 12, 2025
Insider Transaction Report
Form 4
Tupper Colleen
EVP & Chief Financial Officer
Transactions
- Award
Common Stock
2025-02-10+26,957→ 209,570 total - Award
Common Stock
2025-02-10+51,768→ 182,613 total - Tax Payment
Common Stock
2025-02-10$30.52/sh−8,109$247,487→ 201,461 total - Tax Payment
Common Stock
2025-02-10$30.52/sh−22,317$681,115→ 179,144 total
Footnotes (4)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2026, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
- [F2]Effective February 10, 2025, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 26,957 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.
- [F3]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.
- [F4]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.